Femasys' (FEMY) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Femasys (NASDAQ:FEMY – Free Report) in a research report released on Thursday, Benzinga reports. HC Wainwright currently has a $5.00 price objective on the stock. Femasys Price Performance NASDAQ:FEMY opened at $0.43 on Thursday. The firm has a market cap of $6.48 million, a P/E ratio […]

Related Keywords

Canada ,United States ,Hong Kong ,Japan , ,Femasys Company Profile ,Vanguard Group Inc ,Clear Creek Financial Management ,Cetera Advisor Networks ,Nasdaq ,Virtu Financial ,Femasys Inc ,Free Report ,Get Free Report ,Advisor Networks ,Creek Financial Management ,Femasys Daily ,Femasys ,Nasdaq Femy ,Femy ,Medical ,Reiterated Rating ,Hc Wainwright ,